Qvella Corp is a global biotechnology company headquartered in Richmond Hill, Canada, with offices in Carlsbad, California, and Mechelen, Belgium. Their vision is to enable faster clinical decisions for better patient outcomes through their innovative Sepsis FAST System and FAST-ID BSI technologies.
With a focus on improving healthcare, Qvella Corp is dedicated to developing cutting-edge solutions that streamline the diagnosis and treatment of sepsis, a life-threatening condition. Their advanced systems provide healthcare professionals with rapid and accurate results, allowing for quicker interventions and improved patient care.
Generated from the website